🩺

Understanding Chronic Kidney Disease and Management

Aug 20, 2024

Notes on Chronic Kidney Disease (CKD) Lecture by Dr. Nitesh Raj

Introduction to CKD

  • CKD: Chronic Kidney Disease, also known as Chronic Renal Failure.
  • Definition: A disease with gradual damage to the kidneys lasting more than 3 months.
  • Difference from Acute Kidney Injury (AKI):
    • AKI occurs suddenly and can be reversible if treated.
    • CKD is progressive and irreversible.

Causes of CKD

  • Common Causes:
    • Diabetes
    • Hypertension
    • Polycystic Kidney Disease
    • Glomerular Nephritis
    • Drug-induced, especially painkillers.
  • Pathophysiology:
    • Slow, continuous damage to kidneys causing loss of filtration ability.

Symptoms and Diagnosis

  • Symptoms:
    • Volume overload: Puffy eyes, pulmonary edema.
    • Electrolyte imbalances: Sodium and potassium issues.
    • Acidosis: Increased H+ levels; leads to metabolic acidosis.
  • Testing:
    • Estimated Glomerular Filtration Rate (eGFR)
    • Albumin-creatinine ratio for staging the disease.

Complications of CKD

  • Electrolyte Imbalance:
    • Hyperkalemia: High potassium levels; can lead to cardiac arrest.
    • Acidosis: Increased H+ levels; decreased bicarbonate.
  • Bone Health:
    • Calcification: High phosphate levels lead to low calcium; risk of renal osteodystrophy.
  • Anemia: Low erythropoietin production leads to reduced RBC formation.
  • Cardiovascular Risk: Increased risk due to elevated cholesterol and phosphates.

Treatment Options

  • Lifestyle Changes:
    • Control blood pressure and blood sugar.
    • Dietary restrictions: Low protein, low potassium, low phosphate.
  • Medications:
    • Acidosis Management: Sodium bicarbonate.
    • Phosphate Control: Phosphate binders and dietary modifications.
    • Calcium Deficiency: Supplementation with active Vitamin D.
    • Anemia Management: Erythropoietin injections and iron supplements.
  • Hyperkalemia Treatment:
    • Calcium gluconate for cardiac stabilization.
    • Insulin and dextrose to shift potassium into cells.
    • Dietary potassium restriction.

Long-term Management

  • Monitoring: Regular checks on potassium and creatinine levels when on ACE inhibitors or ARBs.
  • Emerging Treatments:
    • N-Acetyl Cysteine (NAC): Antioxidant properties; may help in slowing down CKD progression.
    • Alpha-ketoanalogues: Amino acids without nitrogen, reducing nitrogenous waste.
  • Consultation: Regular follow-ups with nephrologists for tailored treatment plans.

Conclusion

  • CKD is a progressive disease requiring careful management but can be slowed down with appropriate interventions and lifestyle changes.
  • Important to spread awareness and control contributing factors such as diabetes and hypertension.

Note: This summary aims to capture the essential points discussed in the lecture for better understanding of Chronic Kidney Disease.